Loading provider…
Loading provider…
Nephrology Physician in Roseville, CA
NPI: 1124265822Primary Practice Location
KAISER FOUNDATION HOSPITAL - ROSEVILLE
1600 Eureka Rd, Roseville, CA
Primary Employer
SUMMIT NEPHROLOGY MEDICAL GROUP, INC.
HQ Phone
Get M.D Sourabh's Phone Numberphone_androidMobile
Get M.D Sourabh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2009 - 2027
NY State Medical License
2024 - 2026

American Board of Internal Medicine
Nephrology
Zucker School of Medicine at Hofstra/Northwell
Residency • Internal Medicine
2006 - 2009
B.J. Medical College - University of Pune
Medical School
Until 2002
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Nephrology
2009 - 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 206 | 333 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 88 | 88 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 65 | 107 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 26 | 34 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 17 | 18 |
Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.
Authors: Gary Rosenthal
Publication Date: 2013-01-26
Authors: Kharait, Sourabh, Haddad, Daniel J, Springer, Matthew L
Journal: Biochem Biophys Res Commun
Publication Date: 2011-05-20
Authors: Mamoune, Asmaa, Kassis, Jareer, Kharait, Sourabh, Kloeker, Susanne, Manos, Elisabeth, Jones, David A, Wells, Alan
Journal: Exp Cell Res
Lead Sponsor: Christopher Granger, MD
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: warfarin, DRUG: apixaban